Extracorporeal Life Support in Infarct-Related Cardiogenic Shock.
Holger ThieleUwe ZeymerIbrahim AkinMichael BehnesTienush RassafAmir Abbas MahabadiRalf LehmannIngo EitelTobias GrafTim SeidlerAndreas SchusterCarsten SkurkDaniel DuerschmiedPeter ClemmensenMarcus HennersdorfStephan FichtlschererIngo VoigtMelchior SeyfarthStefan JohnSebastian EwenAxel LinkeEike TiggesPeter NordbeckLeonhard BruchChristian JungJutta FranzPhilipp LautenTomaz GoslarHans-Josef FeistritzerJanine PössEva KirchhofTaoufik OuarrakSteffen SchneiderSteffen DeschAnne Freundnull nullPublished in: The New England journal of medicine (2023)
In patients with acute myocardial infarction complicated by cardiogenic shock with planned early revascularization, the risk of death from any cause at the 30-day follow-up was not lower among the patients who received ECLS therapy than among those who received medical therapy alone. (Funded by the Else Kröner Fresenius Foundation and others; ECLS-SHOCK ClinicalTrials.gov number, NCT03637205.).